Active ingredient
Fluindione
PREVISCAN is usually prescribed for:
Prevention of thromboembolic accident in case of emboligenic heart disease
Prevention of thromboembolic accident following myocardial infarction
Prevention of thromboembolic accident in case of valve prosthesis wearing
Deep vein thrombosis
Pulmonary embolism
Indications PREVISCAN-
Renewal of a balanced treatment with fluindione in the following indications:
· Emboligenic heart disease: prevention of thromboembolic complications related to certain atrial rhythm disorders (atrial fibrillation, flutter, atrial tachycardia), certain mitral valvulopathies, valvular prostheses.
Prevention of thromboembolic complications of complicated myocardial infarction: mural thrombus, severe left ventricular dysfunction, emboligenic dyskinesia, etc.
· Treatment of deep vein thrombosis and pulmonary embolism as well as the prevention of their recurrence.
These indications are detailed in the Dosage and method of administration / Biological monitoring section.
No comments:
Post a Comment
اكتب تعليق حول الموضوع